Related Experiment Video
Updated: Aug 11, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Irreversible neurological worsening following high-dose corticosteroids in advanced progressive multiple sclerosis
Marcus Koch1, Jacques De Keyser
1Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands. m.w.koch@neuro.umcg.nl
Background:
A course of high-dose corticosteroids has been shown to hasten recovery from a relapse of multiple sclerosis (MS). Some patients with progressive MS ask for a course with corticosteroids outside a relapse, hoping to gain some functional improvement.
Objective:
To describe 4 patients with advanced progressive MS who experienced worsening of disability after treatment with high-dose corticosteroids.
Results:
All 4 patients had moderate to severe disability and asked for corticosteroid treatment because they were slowly progressing. None of them had a relapse. All experienced improvement by the end of the treatment course. One or 2 days after discontinuation of treatment, however, they deteriorated clinically and became more disabled than before treatment.
Conclusion:
The use of high-dose corticosteroid therapy in progressive forms of MS outside relapses can be detrimental and worsen disability.
Related Concept Videos
Multiple Sclerosis l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Parkinson's Disease: Overview
Hepatic Encephalopathy
Increased Intracranial Pressure ll: Pathophysiology
